| Literature DB >> 30593379 |
Zhiyuan He1, Xiang Chen1, Mengjiao Fu1, Jun Tang1, Xiaoqi Li2, Hong Cao1, Yongqiang Wang3, Shijun J Zheng4.
Abstract
Fowl Adenoviruses (FAdVs) are widely-distributed pathogens across the globe. Fowl adenovirus serotype 4 (FAdV-4), the causative agent for chicken hydropericardium syndrome (HPS) with a high mortality in the infected flocks, has caused severe economic losses to the poultry industry of China in the past few years. Although vaccination against FAdV-4 has been implemented, the prevention and control of FAdV-4 infection is still not very successful. Here, we report that FAdV-4 markedly inhibits Leghorn male hepatoma (LMH) cell growth and this inhibition could be abolished by a small molecule SP600125, a JNK MAPK specific inhibitor. Furthermore, SP600125 considerably suppressed FAdV-4-induced phosphorylation of p38 and JNK MAPK. Importantly, SP600125 promoted type I interferon production associated with inhibition of FAdV-4 replication. Thus, FAdV-4 might employ the JNK MAPK pathway for the benefit of its replication, and SP600125 may have the potential of being used as an anti-virus drug for the control FAdV-4 infection.Entities:
Keywords: Fowl adenovirus serotype 4 (FAdV-4); Inhibitor SP600125; JNK MAPK signaling pathway; Type I interferon
Mesh:
Substances:
Year: 2018 PMID: 30593379 DOI: 10.1016/j.vetmic.2018.11.014
Source DB: PubMed Journal: Vet Microbiol ISSN: 0378-1135 Impact factor: 3.293